Speaker 2: Yasumasa Okamoto
نویسندگان
چکیده
s | 33 receptor antagonist DU-125530 for antidepressant treatment. Br J Pharmacol 2012; 167:1021–1034 Hughes ZA, Starr KR, Langmead CJ, Hill M, Bartoszyk GD, Hagan JJ, Middlemiss DN, Dawson LA. Neurochemical evaluation ofhe novel 5HT1A receptor partial agonist/serotonin reuptakeinhibitor, vilazodone. Eur J harmacol. 2005;510:49–57. Sanchez C, Asin KE, Artigas F. Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data. Pharmacol Ther 2015; 145:43–57 Ferrés-Coy A, Santana N, Castañé A, Cortés R, Carmona MC, Toth M, Montefeltro A, Artigas F, Bortolozzi A Acute 5-HT(1A) autoreceptor knockdown increases antidepressant responses and serotonin release in stressful conditions. Psychopharmacology 2013; 225:61–74 Bortolozzi A, Castañé A, Semakova J, Santana N, Alvarado G, Cortés R, Ferrés-Coy A, Fernández G, Carmona MC, Toth M, Perales JC, Montefeltro A, Artigas F (2012) Selective siRNA-mediated suppression of 5HT(1A) autoreceptors evokes strong antidepressant-like effects. Mol Psychiatry 2012; 17:612–23 Speaker 2: Yasumasa Okamoto Title: The role of serotonin in waiting for future rewards in depression Yasumasa Okamoto, Go Okada, Saori Tanaka, Kayoko Miyazaki, Katsuhiko Miyazaki, Kenji Doya, Shigeto Yamawaki 1Department of Psychiatry and Neurosciences, Graduate School of Biomedical Sciences, Hiroshima University 2 Computational Neuroscience Laboratories, Advanced Telecommunications Research Institute, Kyoto, Japan 3Neural Computation Unit, Okinawa Institute of Science and Technology Graduate University, Okinawa 904-0495, Japan Abstract Serotonin (5-HT) is a major neuromodulator implicated in a broad assortment of behavioral and physiological functions, including aggression, appetite, aversion, behavioral inhibition and impulsivity. The 5-HT system is one of the most important targets for the treatment of depression. It has been difficult, however, to explain the diverse effects of serotonin on adaptive behavior within a unified framework. Based on the review of experimental data and theoretical models, we previously proposed a model in which the function of serotonin is to modulate the value of waiting for a future reward. In this hypothesis,Serotonin (5-HT) is a major neuromodulator implicated in a broad assortment of behavioral and physiological functions, including aggression, appetite, aversion, behavioral inhibition and impulsivity. The 5-HT system is one of the most important targets for the treatment of depression. It has been difficult, however, to explain the diverse effects of serotonin on adaptive behavior within a unified framework. Based on the review of experimental data and theoretical models, we previously proposed a model in which the function of serotonin is to modulate the value of waiting for a future reward. In this hypothesis, a higher level of 5-HT means a higher setting of the discount factor, which promotes waiting for longer delays. A low level of serotonin is often associated with impulsive behaviors (Doya, 2002). Here, we show a part of the results of a series of research carried out based on the hypothesis. Human functional magnetic resonance imaging (fMRI) studies show differential involvement of brain areas in the prediction of immediate and delayed rewards, with the dorsal striatum and prefrontal cortex showing consistent activity for delayed rewards (Tanaka et al., 2004). To elucidate the role of serotonin in the evaluation of delayed rewards, we performed an fMRI experiment in which subjects chose either small-immediate or large-delayed rewards under dietary regulation of tryptophan, a precursor of serotonin. The study showed that the dorsal striatal activity correlated with long-term reward prediction was enhanced with the activation of the serotonergic system (Tanaka et al., 2007). From the behavioral data, we found an increase of proportion in small reward choices, together with an increase in the rate of discounting of delayed rewards in the low-serotonin condition compared with the control and highserotonin conditions (Schweighofer et al., 2008). Recently, we found the attenuated activation in the dorsal striatum during waiting for delayed rewards in depressed patients (Okada et al., in preparation). To examine any causal relationship between serotonergic activity and waiting behavior for delayed reward, we applied a 5-HT1A receptor agonist locally in the dorsal raphe nucleus (DRN) in rats; this treatment is known to suppress 5-HT neural activity through autoreceptors. Rats performed a sequential food-water navigation task in which they alternately visited food and water sites to acquire rewards after waiting periods. The rats performed the task under two reward conditions: a short delayed reward condition and a long delayed reward condition. We found that the suppression of 5-HT neural activity in the DRN by a 5-HT1A receptor agonist increased premature exit from reward sites before the delivery of delayed rewards, which indicated impaired patience for delayed rewards (Miyazaki et al., 2012). From both human and animal studies, these results strongly supported our hypothesis that 5-HT promotes waiting for longer delays, and might explain not only impulsive behavior, but also certain aspects of depressive behavior.
منابع مشابه
PS244. Depression severity and related characteristics correlate significantly with activation in brain areas selected through machine learning
متن کامل
Author's response to reviews Title: Psychosocial functioning in patients with treatment-resistant depression after group cognitive behavioral therapy Authors:
متن کامل
Manuscript Category: Review Resting-state functional connectivity-based biomarkers and functional MRI-based neurofeedback for psychiatric disorders: a challenge for developing theranostic biomarkers
236; Manuscript: 5976
متن کاملPS228. Subthreshold depression persists and increases the risk for depression in late adolescence: a one-year cohort study.
s | 83 included) and Mantel Haenszel-Risk Ratio of 1.31, 95% CI=1.01 to 1.69 (p=0.04) favouring active treatment over placebo according to response rates (12 studies included). Trials were patients merely had BLT as active treatment indicated a higher effect size (Hedges`s g= -0.51, 95%CI =-0.70 to -0.32 and p=0.001) than studies with concomitant psychopharmacological treatment (Hedges`s g= -0....
متن کاملPhase I pharmacokinetic study of S-1 granules and nedaplatin for advanced head and neck cancer.
AIM We performed a pharmacokinetic phase I trial of the combination of S-1 granules and nedaplatin for head and neck squamous cell carcinoma (HNSCC). PATIENTS AND METHODS Patients were treated with both nedaplatin on day 1 at a dose starting at 80 mg/m(2) (level 1) escalating up to 90 mg/m(2) (level 2), and S-1 granules at a daily dose of 80 mg/m(2) on days 1 to 14 every three weeks. The prim...
متن کامل